Contemporary OB/GYN/LinkedIn
Jan 18, 2026, 07:48
DSMB Review Confirms Safety of Brexanolone for PPD – Contemporary OB/GYN
Contemporary OB/GYN shared a post on LinkedIn:
“A phase 3 trial of Lipocine Inc.‘s oral formulation of brexanolone, LPCN 1154, for postpartum depression, will continue without any modification following the completion of a second independent Data Safety Monitoring Board review.
In the second and last review, the DSMB found no safety concerns in the trial.
More details and more on the makeup of the trial.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
-
Oct 28, 2026, 15:37Gili Band: The People Are What Stay With Me After Day 1 at ASRM 2026
-
Oct 28, 2026, 13:56Samantha Payne: NSW Releases Final Report on Fertility Support and Assisted Reproductive Treatment
-
Oct 28, 2026, 13:53True Friendship and PCOS: Why Emotional Support Matters – PCOS Millennials
-
Oct 28, 2026, 13:51Fred Ushakov: The Future of Prenatal Screening, The Future of Your Practice
-
Oct 28, 2026, 13:49Hosting the First-Ever Fairfax Awards – Fairfax EggBank